The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


NASONEX 50 micrograms/actuation Nasal Spray, Suspension



PCO Manufacturing Ltd.PPA0465/146/001

Main Information

Trade NameNASONEX 50 micrograms/actuation Nasal Spray, Suspension
Active SubstancesMometasone furoate
Dosage FormNasal spray, suspension
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/146/001

Group Information

ATC CodeR01AD Corticosteroids
R01AD09 mometasone

Status

Authorised/WithdrawnAuthorised
Licence Issued19/08/2005
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis authorisation permits the holder to parallel-distribute only the product marketed in Ireland under the product authorisation PA1286/038/001.
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back